Send mail to Author

Patient-reported outcomes with risankizumab versus fumaric acid esters in systemic therapy-naïve patients with moderate to severe plaque psoriasis: a phase 3 clinical trial (Article)

Please indicate your contact information and select, which author you want to contact.



 
  ______    ______    _____      ___     _    _     _____   
 /_____//  /_   _//  / ____||   / _ \\  | \  / ||  |  ___|| 
 `____ `    -| ||-  / //---`'  | / \ || |  \/  ||  | ||__   
 /___//     _| ||_  \ \\___    | \_/ || | .  . ||  | ||__   
 `__ `     /_____//  \_____||   \___//  |_|\/|_||  |_____|| 
 /_//      `-----`    `----`    `---`   `-`  `-`   `-----`  
 `-`
 


Back to frontdoor view

OPUS4 Logo